These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9766781)

  • 1. Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions.
    Woods SW; Sholomskas DE; Shear MK; Gorman JM; Barlow DH; Goddard AW; Cohen J
    Am J Psychiatry; 1998 Oct; 155(10):1446-8. PubMed ID: 9766781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research design features and patient characteristics associated with the outcome of antidepressant clinical trials.
    Khan A; Kolts RL; Thase ME; Krishnan KR; Brown W
    Am J Psychiatry; 2004 Nov; 161(11):2045-9. PubMed ID: 15514405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the treatment of schizoaffective disorder.
    McElroy SL; Keck PE; Strakowski SM
    J Clin Psychiatry; 1999; 60 Suppl 5():16-21; discussion 22. PubMed ID: 10192403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The statistical comparison of clinical trials.
    Schooler NR
    J Clin Psychiatry; 2001; 62 Suppl 9():35-7; discussion 38-9. PubMed ID: 11379830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of clinical trials of antidepressants.
    Quitkin FM; Rabkin JG; Gerald J; Davis JM; Klein DF
    Am J Psychiatry; 2000 Mar; 157(3):327-37. PubMed ID: 10698806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrating drug action.
    Tamminga CA
    Am J Psychiatry; 2004 Jun; 161(6):943-5. PubMed ID: 15169679
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo effect in depression.
    Carpenter WT
    Am J Psychiatry; 2009 Aug; 166(8):935. PubMed ID: 19651755
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal sample allocation in clinical trials designed to investigate relative risks.
    Eastwood BJ
    Stat Med; 1996 Dec; 15(23):2523-38. PubMed ID: 8961461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating characteristics of patient selection and dropout rates.
    Keith SJ
    J Clin Psychiatry; 2001; 62 Suppl 9():11-4; discussion 15-6. PubMed ID: 11379825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ideal trial to test differential onset of antidepressant effect.
    Leon AC; Blier P; Culpepper L; Gorman JM; Hirschfeld RM; Nierenberg AA; Roose SP; Rosenbaum JF; Stahl SM; Trivedi MH
    J Clin Psychiatry; 2001; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 17. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.